Common Targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm.
Common Targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm.
Eur J Pharmacol. 2020 Dec 22;:173805
Authors: Gajjar S, Patel BM
Abstract
Colon cancer is a major health issue and number of cases are increasing every year. Diabetes mellitus is also a significant health issue that is growing day by day worldwide having negative influences on the survival of individuals. Research has shown a strong relationship between the two malignant diseases. The risk of colon cancer with patients who have type 2 diabetes mellitus has spiked by 30%. The scientific research suggests insulin has a major role in the spread of cancer and the condition unifying between the two diseases is hyperinsulinemia. Several anti-diabetic agents are used for the treatment of type 2 diabetesmellitus. However, their mechanism of action against cancer activity is a question and only a few agents have shown positive signs of action in colon cancer associated with type 2 diabetesmellitus. Hence, the identification of targets, which is common for both colon cancer, associated with type 2 diabetesmellitus has become an urgent requirement. Novel targets such as Liver X receptors, Histone deacetylase inhibitors (HDACi), Glucose Transporters (GLUTs), Peroxisome proliferator activator receptors (PPARs), Dipeptidyl peptidase-IV inhibitors (DPP4i), Cyclin-dependent kinase 4 inhibitors (CDK4i), Estrogen receptors,Mechanistic target of rapa...
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Gajjar S, Patel BM Tags: Eur J Pharmacol Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Fish | Insulin | Liver | Science | Urology & Nephrology